| 000 | 01849 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516160237.0 | ||
| 264 | 0 | _c20140911 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1936-959X | ||
| 024 | 7 |
_a10.3174/ajnr.A3621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelgado Almandoz, J E | |
| 245 | 0 | 0 |
_aLast-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device. _h[electronic resource] |
| 260 |
_bAJNR. American journal of neuroradiology _cJan 2014 |
||
| 300 |
_a128-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xblood |
| 650 | 0 | 4 |
_aEmbolization, Therapeutic _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracranial Aneurysm _xblood |
| 650 | 0 | 4 |
_aIntracranial Embolism _xblood |
| 650 | 0 | 4 |
_aIntracranial Thrombosis _xblood |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xblood |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCrandall, B M | |
| 700 | 1 | _aScholz, J M | |
| 700 | 1 | _aFease, J L | |
| 700 | 1 | _aAnderson, R E | |
| 700 | 1 | _aKadkhodayan, Y | |
| 700 | 1 | _aTubman, D E | |
| 773 | 0 |
_tAJNR. American journal of neuroradiology _gvol. 35 _gno. 1 _gp. 128-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3174/ajnr.A3621 _zAvailable from publisher's website |
| 999 |
_c22893022 _d22893022 |
||